Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2026-03-13 @ 3:43 PM
Study NCT ID:
NCT01960634
Status:
COMPLETED
Last Update Posted:
2015-05-05
First Post:
2013-10-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
Sponsor:
Grupo Español Multidisciplinar de Melanoma
Organization:
Study Overview
Official Title:
Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BRAFV600
Brief Summary:
This is a multi-centric translational study with biological samples collection. The aim of this study is to validate a method to detect BRAFV600 in blood samples.
Samples: Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice.
The treatment is not the aim of the study. Patients can be treated either with specific or no-specific drug.
Samples: Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice.
The treatment is not the aim of the study. Patients can be treated either with specific or no-specific drug.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| GEM-1304 | OTHER | Sponsor | View |